Keyphrases
6-mercaptopurine (6-MP)
20%
Acute Lymphoblastic Leukemia
92%
Acute Myeloid Leukemia
24%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
35%
Antibiotics
8%
Asthma
9%
At Birth
14%
Bacillus Calmette
8%
Blood Samples
9%
Body Mass Index
10%
Bovine Colostrum
9%
C-reactive Protein
8%
Cancer Treatment
9%
Central Nervous System
8%
Central Nervous System Tumors
12%
Cerebral Palsy
20%
Cerebral Palsy children
9%
Chemotherapy
14%
Childhood Acute Lymphoblastic Leukemia
81%
Childhood Cancer
18%
Childhood Cancer Survivors
8%
Childhood Leukemia
10%
Children with Cancer
22%
Clinical Trials
9%
Confidence Interval
59%
Copenhagen
9%
COVID-19
11%
Cystic Fibrosis
68%
Denmark
89%
Early Diagnosis
8%
Epilepsy
12%
Etiology
9%
Europe
12%
Event-free Survival
13%
Genotype
13%
Germ Cells
9%
Gestational Age
10%
Graft-versus-host Disease (GvHD)
12%
Growth Factors
8%
Hazard Ratio
24%
Healthcare Professionals
10%
Healthy children
11%
Healthy Controls
9%
Hematopoietic Stem Cell Transplantation
35%
High Risk
22%
Hospitalization
17%
Incidence Rate
12%
Insulin-like
8%
L-asparaginase
16%
Leukemia
16%
Leukemia Patients
8%
Lung Function
17%
Maintenance Therapy
21%
Meta-analysis
16%
Methotrexate
17%
Minimal Residual Disease
16%
National Cohort Study
23%
Necrotizing Enterocolitis
11%
Neonate
11%
Nordic Countries
10%
Odds Ratio
17%
Older Adults
30%
Overall Survival
14%
Pathogenic Variants
8%
Pediatric
43%
Pediatric Acute Lymphoblastic Leukemia
12%
Pediatric Hematology
18%
Pediatric Leukemia
10%
Pediatric Oncology
25%
Pediatric Patients
27%
Pharmacokinetics
8%
Physical Activity
12%
Placebo
9%
Population-based
13%
Population-based Cohort Study
18%
Population-based Study
8%
Preterm Birth
8%
Preterm Infants
16%
Preterm pigs
18%
Primary Ciliary Dyskinesia
41%
Pseudomonas Aeruginosa (P. aeruginosa)
16%
Quality of Life
13%
Radiotherapy
8%
Randomized Clinical Trial
14%
Randomized Controlled Trial
17%
Register Study
10%
Relapse Risk
11%
Respiratory Syncytial Virus
9%
Rett Syndrome
8%
Risk Factors
29%
Seizure
9%
Survivors
24%
Systematic Meta-analysis
11%
Systemic Juvenile Idiopathic Arthritis (sJIA)
22%
Thiopurine Methyltransferase
11%
Tumor
10%
Vaccination
18%
Wilms Tumor
12%
Working Diagnosis
15%
Young children
10%
Medicine and Dentistry
Acute Lymphoblastic Leukemia
100%
Acute Myeloid Leukemia
23%
Adolescent
49%
Adverse Event
9%
Allogeneic Hematopoietic Stem Cell Transplantation
13%
Antibiotics
12%
Arm
6%
Asparaginase
8%
Asthma
9%
B Cell
6%
Bacilli
7%
Biological Marker
7%
Birth Weight
6%
Body Mass Index
8%
Brain Tumor
8%
Breathing
12%
Cancer Therapy
6%
Cell Transplantation
6%
Central Nervous System
10%
Central Nervous System Tumor
10%
Childbirth
31%
Childhood Cancer
28%
Clinical Trial
10%
Cohort Analysis
65%
Cohort Effect
7%
COVID-19
7%
Cryptorchism
6%
Cystic Fibrosis
40%
Diabetes
7%
Diagnosis
25%
Disease
71%
Disease Course
6%
Drug Megadose
10%
Drug Therapy
8%
Early Diagnosis
6%
Epilepsy Surgery
6%
Epileptic Seizure
14%
Event Free Survival
10%
Exercise
6%
Flow Cytometry
6%
Gestational Age
8%
Gut
7%
Hazard Ratio
20%
Hematopoietic Stem Cell
6%
Hematopoietic Stem Cell Transplantation
27%
Infancy
6%
Infection
42%
Insulin Dependent Diabetes Mellitus
10%
Juvenile Idiopathic Arthritis
15%
Late Effect
7%
Leukemia
15%
Leukocyte
7%
Liver Disease
9%
Magnetic Resonance Imaging
8%
Maintenance Therapy
11%
Malignant Neoplasm
45%
Medicine
6%
Mercaptopurine
11%
Meta-Analysis
13%
Methotrexate
15%
Minimal Residual Disease
16%
Necrotizing Enterocolitis
7%
Neonatal Infant
18%
Neonate
8%
Neoplasm
28%
Newborn Screening
6%
Odds Ratio
14%
Out of Hospital Cardiac Arrest
6%
Overall Survival
15%
Pancreatitis
6%
Patient with Cystic Fibrosis
12%
Pediatric Acute Myeloid Leukemia
8%
Pediatric Hematology
14%
Pediatric Oncology
13%
Pediatrics
97%
Pediatrics Patient
19%
Persistent Truncus Arteriosus
8%
Physical Activity
9%
Placebo
10%
Precursor
6%
Prematurity
10%
Prevalence
17%
Primary Ciliary Dyskinesia
30%
Proportional Hazards Model
6%
Pseudomonas aeruginosa
7%
Quality of Life
14%
Radiation Therapy
10%
Randomized Clinical Trial
11%
Randomized Controlled Trial
17%
Serositis
6%
Severe Acute Respiratory Syndrome Coronavirus 2
10%
Silo-Filler's Disease
8%
Spastic Diplegia
17%
Surgery
6%
Symptom
34%
Systematic Review
19%
T Cell
6%
Testes
6%
Toddlers
7%
Wilms' Tumor
11%